Previous 10 | Next 10 |
Thomson Reuters ONE news releases related Thomson Reuters One news releases and Thomson Reuters One press releases from 11/06/19 07:30:00 on US and Canada...
Biogen to gain exclusive commercialization rights to two new ophthalmology biosimilars referencing Lucentis and Eylea in the U.S., Canada, Europe, Japan and Australia Will provide Biogen with commercialization rights for its current anti-TNF biosimilars portfolio in China, adding to its st...
Montrouge, France, November 5, 2019 DBV Technologies to Present at the Stifel 2019 Healthcare Conference DBV Technologies, (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Kevin Trapp, Chief Commercial Off...
London, November 5, 2019 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI), today announced its agreement to acquire ATI Inc., a global manufacturer of rubber track systems for high horsepower tractors and combine harvesters. This acquisition will provide customers of CNH Industrial’s globa...
~ Third uniQure U.S. Patent Covering the Treatment of Hemophilia B and Other Bleeding Disorders using FIX-Padua in AAV Gene Therapy ~ LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 05, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing ...
Financial Highlights Total revenue decreased to €250.3 million in the third quarter of 2019, compared to €253.7 million in the same period in 2018, representing a decline of 1% period-over-period. In the third quarter of 2019 Referral Revenue in Americas increased by 19% c...
ENDEAVOUR REPORTS Q3-2019 RESULTS Production up 6% and AISC flat · Operating Cash Flow doubled · Net Debt reduced by $52m OPERATIONAL AND FINANCIAL HIGHLIGHTS (for continuing operati...
ENDEAVOUR REPORTS Q3-2019 RESULTS Production up 6% and AISC flat · Operating Cash Flow doubled · Net Debt reduced by $52m OPERATIONAL AND FINANCIAL HIGHLIGHTS (for continuing operati...
Third Quarter 2019 Highlights Net sales increased by 7% to $464.5 million as compared to $434.5 million in the prior year quarter Consolidated gross profit margin increased by over 400 basis points Net income of $22.4 million and Adjusted EBITDA 1 of $80.0 million exceeded prior ...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage bispecific antibody company developing Biclonics ® , today announced the launch of a proposed underwritten public offering of up to $60.0 million of its common shar...
CAMBRIDGE, Mass., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) today announced it will host live webcasts of its oral presentation and a Q&A session related to its Alzheimer’s disease investigational therapy, aducanumab, at the upcoming Clinical Trials on Alzheimer ...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
100.0%Change Percent:
First Capital Real Estate Investment Trust - Unit Company Name:
FCXXF Stock Symbol:
OTCMKTS Market:
fcr.ca Website: